Back to Startups

Chai Discovery

About Chai Discovery

Chai Discovery is a biotech AI company focused on building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.

Business Information
Target Customers
biotech companies pharmaceutical companies research institutions
Industry Categories
Bioscience & Disease AI, ML, Gen AI Deep Tech
Business Model
Revenue Model B2B SaaS
Pricing Strategy Custom pricing based on usage and services
Sales Channels direct sales, partnerships with research institutions
Funding Timeline
Round Date Amount Investors
Series A Aug 08, 2025 $70.0M Menlo Ventures, Anthology Fund, Anthropic
Founders
J
Joshua Meier

Co-Founder & CEO

J
Jack Dent

Co-Founder & President

M
Matthew McPartlon

Co-Founder & Chief Technology Officer (CTO)

J
Jacques Boitreaud

Co-Founder & CEO

Investors
A
Anthology Fund

Venture Capital

A
Anthropic

Corporate

M
Menlo Ventures

Venture Capital

Recent Mentions
TradedVC
Traded: Venture Capital @TradedVC
Aug 08, 2025

Chai Discovery, a biotech AI company founded in 2024 by Joshua Meier (CEO), Jack Dent, Matthew McPartlon, and Jacques Boitreaud, recently raised $70 million in a Series A round led by Menlo Ventures and its Anthology Fund in partnership with Anthropic. With backing from both... https://t.co/KYqomXRTQB

wwwAIblog
AI Blog @wwwAIblog
Aug 09, 2025

Artificial intelligence company Chai Discovery announced Tuesday it has closed a $70 million Series A funding round, positioning the startup to advance its machine learning platform that designs antibodies and drug molecules from scratch. https://t.co/gJFYKuDVbo The San https://t.co/tbGNkpY4ij